Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

tucatinib

(too-KA-tih-nib)
A drug used with other drugs to treat adults with certain types of HER2-positive breast cancer or certain types of HER2-positive colorectal cancer that do not have a mutation (change) in the RAS gene. It is also being studied in the treatment of other types of cancer. Tucatinib blocks a protein called HER2, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called Tukysa.
More Information
Search NCI's Dictionary of Cancer Terms